Businesses that are solid enough to perform well over extended periods, while consistently raising their payouts, are precisely what income investors should gravitate toward. Here are two corporations ...

A heads-up for drivers in Huntersville.

Shares of Gilead Sciences Inc. GILD shed 1.27% to $96.91 Friday, on what proved to be an all-around dismal trading session ...

The new plans are in addition to $21B that the drug manufacturer has already committed to U.S. research, development and ...

Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

In their first musical in many years, Actors Co-Op Theatre is presenting The Spitfire Grill which highlights the bonds of ...

The U.S. Attorney’s Office for the Southern District of New York last week announced the resolution of two significant False Claims Act ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

The trial is aimed at assessing long-term efficacy as well as safety of the therapy in 150 chronic HDV patients.

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...